Concepedia

Mark Lipstein

ML

Statistics

Publications

4

Citations

189

H-Index

4

Active since

1977

Affiliations

Columbia University Irving Medical Center(Current)

Mark Lipstein is an author at Columbia University Irving Medical Center specializing in oncology, medicine, and hematologic malignancy therapy.

Publications per year

1977–2016

4

Publications

4

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies

Changchun Deng, Mark Lipstein, Luigi Scotto et al. · Blood · 2016 · 105 citations · Full text

Medicine, Cancer Biology, Oncology +14

Bortezomib-Induced Tumor Lysis Syndrome in a Patient With HIV-Negative Plasmablastic Lymphoma

Mark Lipstein, Owen O’Connor, Francesca Montanari et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 35 citations

Medicine, Hematology, Oncology +13

The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB

Changchun Deng, Mark Lipstein, Richard Rodríguez et al. · Clinical Cancer Research · 2014 · 26 citations

Medicine, Oncology, Pharmacology +14

PSEUDOMONAS CEPACIA IN THE RESPIRATORY FLORA OF PATIENTS WITH CYSTIC FIBROSIS (CF)

Lourdes R. Laraya-Cuasay, Mark Lipstein, Nancy Ν. Huang · Pediatric Research · 1977 · 23 citations

Life Sciences, Microbiology, Bacteriology +11

1–4 of 4